Compare AbCellera Biologics Inc (ABCL) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs United States Natural Gas Fund — how do they compare? AbCellera Biologics Inc trades at $7.18 (market cap $2.35B), while United States Natural Gas Fund trades at $11.61. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| ABCL | UNG | |
|---|---|---|
Market Cap | $2.35B | — |
Sector | Health | Commodities - Energy |
52-Week High | $8.12 | $16.90 |
52-Week Low | $2.78 | $10.15 |
Enterprise Value | $1.99B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 5.18% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of -$146.41M in 2025, with negative margins, though revenue grew to $75.13M. Recent news highlights a major collaboration with Jazz Pharmaceuticals worth up to $876M, potentially boosting future revenue streams. Analyst consensus is strongly bullish with a $9.67 price target, indicating 25.7% upside.
The outlook hinges on execution of new partnerships and pipeline progress, particularly ABCL635 Phase 2 data expected in Q3 2026. Key risks include persistent cash burn, high valuation multiples despite losses, and biotech sector volatility. Investors should weigh the strong analyst support against fundamental challenges and the stock's current technical overbought condition.
UNG trades at $11.71, up 1.12% today, with a bullish technical signal driven by moving averages. The fund tracks natural gas futures, with sentiment influenced by weather-driven demand and LNG export flows. Recent news highlights volatility from storage data and production forecasts, while technical indicators like RSI remain neutral.
Outlook hinges on natural gas price trends, with upside from demand spikes but risks from contango and ample supply. Investors face structural challenges, as noted in analysis citing decade-long losses, requiring caution despite short-term bullish signals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
